DexCom (Germany) Top Insiders
| DC4 Stock | EUR 61.93 0.59 0.96% |
DexCom employs about 11 K people. The company is managed by 15 executives with a total tenure of roughly 25667 years, averaging almost 1711.0 years of service per executive, having 733.33 employees per reported executive. Examination of DexCom's management performance can provide insight into the company performance.
| Jacob Leach CEO CEO President |
DexCom |
DexCom Management Team Effectiveness
The company has return on total asset (ROA) of 0.0889 % which means that it generated a profit of $0.0889 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.345 %, meaning that it generated $0.345 on every $100 dollars invested by stockholders. DexCom's management efficiency ratios could be used to measure how well DexCom manages its routine affairs as well as how well it operates its assets and liabilities. At this time, DexCom's Other Current Assets are most likely to increase significantly in the upcoming years.The DexCom's current Net Income Applicable To Common Shares is estimated to increase to about 412 M, while Common Stock Shares Outstanding is projected to decrease to roughly 245.5 M. DexCom holds a total of 384.86 Million outstanding shares. The majority of DexCom Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in DexCom Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in DexCom. Please pay attention to any change in the institutional holdings of DexCom Inc as this could imply that something significant has changed or is about to change at the company. Also note that almost seven hundred sixty-nine thousand seven hundred thirty invesors are currently shorting DexCom expressing very little confidence in its future performance.
Some institutional investors establish a significant position in stocks such as DexCom in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of DexCom, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
DexCom Workforce Comparison
DexCom Inc is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 24,046. DexCom totals roughly 11,000 in number of employees claiming about 46% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26. DexCom Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. DexCom Inc Price Series Summation is a cross summation of DexCom price series and its benchmark/peer.
DexCom Notable Stakeholders
A DexCom stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DexCom often face trade-offs trying to please all of them. DexCom's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DexCom's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jacob Leach | CEO President | Profile | |
| Jereme CPA | CFO VP | Profile | |
| Girish Naganathan | Executive CTO | Profile | |
| Matthew Dolan | Executive Development | Profile | |
| Donald Abbey | Regulatory, Services | Profile | |
| Jereme Sylvain | CFO VP | Profile | |
| Paul Flynn | Ex Revenue | Profile | |
| Keri Leone | Senior Education | Profile | |
| Kevin Sayer | Executive Board | Profile | |
| Jon Coleman | Executive Officer | Profile | |
| Michael Brown | Executive Officer | Profile | |
| Sadie Stern | Executive Officer | Profile | |
| Sean Christensen | Director Relations | Profile | |
| Steven Pacelli | Ex Ventures | Profile | |
| Andrew Balo | Access Affairs | Profile |
About DexCom Management Performance
The success or failure of an entity such as DexCom Inc often depends on how effective the management is. DexCom management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DexCom management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DexCom management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2800 people.
DexCom Workforce Analysis
Traditionally, organizations such as DexCom use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DexCom within its industry.DexCom Manpower Efficiency
Return on DexCom Manpower
| Revenue Per Employee | 423.8K | |
| Revenue Per Executive | 310.8M | |
| Net Income Per Employee | 76K | |
| Net Income Per Executive | 55.8M | |
| Working Capital Per Employee | 171.9K | |
| Working Capital Per Executive | 126.1M |
Complementary Tools for DexCom Stock analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |